RIGL Price / Book | RIGEL PHARMACEUTICALS, INC.

RIGEL PHARMACEUTICALS, INC. (RIGL) Price / Book

2026-09-03: Price/Book Ratio 2.13.
2026-06-30: Price/Book Ratio 1.7.
2026-03-31: Price/Book Ratio 1.25.
2025-12-31: Price/Book Ratio 2.

Historical market capitalization divided by filed shareholder equity.

Available history: 2010-12-31 to 2026-09-03
Data captured: 2026-09-04

Historical Price/Book Ratio

Date	Price/Book Ratio
2026-09-03	2.13
2026-06-30	1.7
2026-03-31	1.25
2025-12-31	2
2025-09-30	4.32
2025-06-30	4.09
2025-03-31	17.31
2024-12-31	90.6
2022-03-31	755.12
2021-12-31	149.72
2021-09-30	124.86
2021-06-30	108.43
2021-03-31	74.27
2020-12-31	174.16
2020-09-30	79.57
2020-06-30	48.8
2020-03-31	33.5
2019-12-31	66.8
2019-09-30	45.48
2019-06-30	55.74
2019-03-31	45.07
2018-12-31	34.99
2018-09-30	51.64
2018-06-30	37.46
2018-03-31	65.25
2017-12-31	56.6
2017-09-30	56.25
2017-06-30	48.02
2017-03-31	48.14
2016-12-31	42.94
2016-09-30	52.64
2016-06-30	27.87
2016-03-31	24.96
2015-12-31	30.03
2015-09-30	22.68
2015-06-30	27.97
2015-03-31	28.03
2014-12-31	15.58
2014-09-30	11.6
2014-06-30	19.17
2014-03-31	18.03
2013-12-31	11.98
2013-09-30	14.01
2013-06-30	11.88
2013-03-31	22.33
2012-12-31	19.59
2012-09-30	42.04
2012-06-30	34.01
2012-03-31	26.56
2011-12-31	23.85
2011-09-30	20.32
2011-06-30	23.94
2010-12-31	23.69

Similar stocks

Stock Name	Country	Market Cap	PE Ratio
Apnimed, Inc. (APMD)	United States	$0.899B
Theravance Biopharma, Inc. (TBPH)		$0.885B	16.40
Cryoport, Inc. (CYRX)	United States	$0.881B	-21.29
ARDELYX, INC. (ARDX)	United States	$0.857B	-22.86
Jade Biosciences, Inc. (JBIO)	United States	$0.936B	-9.21
Avalo Therapeutics, Inc. (AVTX)	United States	$0.842B	-9.74
Immix Biopharma, Inc. (IMMX)	United States	$0.837B	-18.44
Obsidian Therapeutics, Inc. (OBX)	United States	$0.829B
LEXICON PHARMACEUTICALS, INC. (LXRX)	United States	$0.823B	-17.48
Arbutus Biopharma Corp (ABUS)		$0.965B	6.19